May 13, 2020 / 1:36 PM / 24 days ago

BRIEF-Delmar Pharmaceuticals Reports Q3 Loss Per Share $0.17

May 13 (Reuters) - DelMar Pharmaceuticals Inc:

* DELMAR PHARMACEUTICALS ANNOUNCES FISCAL THIRD QUARTER 2020 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES

* Q3 LOSS PER SHARE $0.17

* AT MARCH 31, 2020, COMPANY HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $5.0 MILLION

* DELMAR PHARMA- CASH,CASH EQUIVALENTS AT MARCH 31, 2020 ARE EXPECTED TO BE SUFFICIENT TO FUND CO’S PLANNED OPERATIONS INTO Q4 OF CALENDAR YEAR 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below